BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18703597)

  • 21. PET/CT of skull base meningiomas using 2-18F-fluoro-L-tyrosine: initial report.
    Rutten I; Cabay JE; Withofs N; Lemaire C; Aerts J; Baart V; Hustinx R
    J Nucl Med; 2007 May; 48(5):720-5. PubMed ID: 17475959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W
    Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical use of digital retrospective image fusion of CT, MRI, FDG-PET and SPECT -- fields of indications and results].
    Lemke AJ; Niehues SM; Amthauer H; Rohlfing T; Hosten N; Felix R
    Rofo; 2004 Dec; 176(12):1811-8. PubMed ID: 15573293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.
    van Baardwijk A; Bosmans G; Boersma L; Buijsen J; Wanders S; Hochstenbag M; van Suylen RJ; Dekker A; Dehing-Oberije C; Houben R; Bentzen SM; van Kroonenburgh M; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):771-8. PubMed ID: 17398018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
    Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].
    Mu DB; Wang SP; Yang WF; Fu Z; Chen XX; Sun XR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):30-3. PubMed ID: 17575690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUV correction for injection errors in FDG-PET examination.
    Miyashita K; Takahashi N; Oka T; Asakawa S; Lee J; Shizukuishi K; Inoue T
    Ann Nucl Med; 2007 Dec; 21(10):607-13. PubMed ID: 18092139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
    Hennings J; Hellman P; Ahlström H; Sundin A
    Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.
    Wehrli NE; Bural G; Houseni M; Alkhawaldeh K; Alavi A; Torigian DA
    Semin Nucl Med; 2007 May; 37(3):195-205. PubMed ID: 17418152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal uptake of 18F-FDG in the testis: an assessment by PET/CT.
    Kitajima K; Nakamoto Y; Senda M; Onishi Y; Okizuka H; Sugimura K
    Ann Nucl Med; 2007 Sep; 21(7):405-10. PubMed ID: 17876554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of unknown primary tumor in a patient with cerebellar metastasis using FDG PET-CT: case report].
    Ishiguro T; Fu Y; Sadatou T; Shimokawa N; Shibamoto K
    No Shinkei Geka; 2006 Oct; 34(10):1027-32. PubMed ID: 17052015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
    Cwikla JB; Nasierowska-Guttmejer A; Jeziorski KG; Cichocki A; Zgliczynski W; Stepień K; Seklecka N; Durlik M; Malkowski B; Walecki J
    Neuro Endocrinol Lett; 2007 Dec; 28(6):789-800. PubMed ID: 18063942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring cancer treatment with PET/CT: does it make a difference?
    Weber WA; Figlin R
    J Nucl Med; 2007 Jan; 48 Suppl 1():36S-44S. PubMed ID: 17204719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
    Belakhlef A; Jani C; Church C; Fraser R; Lakhanpal S
    Clin Nucl Med; 2008 Apr; 33(4):271-2. PubMed ID: 18356666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adequate evaluation of image registration in hybrid PET/CT.
    Vogel WV; van Dalen JA; Oyen WJ
    J Nucl Med; 2006 Sep; 47(9):1556; author reply 1557-8. PubMed ID: 16954568
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan.
    Chen YM; Huang G; Sun XG; Liu JJ; Chen T; Shi YP; Wan LR
    Nucl Med Commun; 2008 May; 29(5):425-30. PubMed ID: 18391725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy.
    Quon A; Napel S; Beaulieu CF; Gambhir SS
    J Nucl Med; 2006 Jul; 47(7):1081-7. PubMed ID: 16818940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.
    Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors.
    Hirasawa S; Tsushima Y; Takei H; Hirasawa H; Taketomi-Takahashi A; Takano A; Oriuchi N; Endo K
    Acad Radiol; 2007 Mar; 14(3):312-8. PubMed ID: 17307664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pitfalls in PET/CT interpretation.
    Cook GJ
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):235-43. PubMed ID: 17464270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.